T. Sakio

Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a cornerstone therapy for patients with heart failure (HF), improving clinical outcomes across the ejection fraction spectrum. However, in real-world practice, their use is often withheld in patients with low body mass index (BMI) due to concerns about potenti...

Two-year clinical outcomes of jetstream atherectomy followed by drug-coated balloon angioplasty for severely calcified femoropopliteal lesions.

A dual-phase study of a bioabsorbable venous vascular closure system: identifying predictors of failure and ensuring long-term safety in over 1,000 procedures

A dual-phase evaluation confirms that the bioabsorbable VVCS is highly effective, although its efficacy is influenced by BMI and sheath size.